Open angle glaucoma is a chronic condition associated with elevated intraocular pressure (IOP). Early stages are usually asymptomatic but as the condition progresses it leads to visual impairment and, ...
Please provide your email address to receive an email when new articles are posted on . Patients who underwent a modified 360° suture trabeculotomy demonstrated a lower mean postop IOP and needed ...
To determine the efficacy and safety of trabeculotomy in congenital glaucoma patients operated on within first 3 months of birth. The mean follow-up was 38.38±11.77 months (range 12–48 months). Mean ...
March 21, 2012 (New York City) — Using the Trabectome (NeoMedix) surgical device to perform ab interno trabeculotomies significantly reduces intraocular pressure (IOP), according to a study presented ...
A retrospective case series involving 19 eyes of 12 consecutive children with primary congenital glaucoma who had primary trabeculotomy–trabeculectomy from 12 August 2004 to 30 June 2008, at the Korle ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
NUREMBURG, Germany — Excimer laser trabeculotomy (ELT) has been successfully carried out in a pilot study of 47 eyes. The procedure had a good intraocular pressure (IOP)-lowering effect, with ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient ...
A large international, multicenter study has shown that creating a full-circumference incision around the trabecular meshwork to lower intraocular pressure (IOP) in open-angle glaucoma, a procedure ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Primary open-angle glaucoma is a condition associated with a long-term increase of pressure within the eye. It may gradually lead to permanent loss of sight because of damage to the nerve that ...
MENLO PARK, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing ...